PACTR202110707328144已完成3 期
Impact of Atorvastatin Reload on the Prevention of Contrast-Induced Nephropathy
hedi chaker hospital0 个研究点目标入组 102 人开始时间: 2021年9月16日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 102
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 19 Year(s) 至 44 Year(s)（—）
- 性别
- All
入选标准
- •This is a prospective, randomized, single-blind, controlled trial, implemented in all consecutive patients (older than 18 years), undergoing coronary angiography or percutaneous coronary intervention in our department between June 2020 and September 2020 and who had already been receiving atorvastatin for at least one week, before admission.
排除标准
- •*patients admitted because of an acute coronary syndrome in whom a loading dose is recommended according to guidelines,
- •*statin-naïve patients,
- •*patients who received a statin other than atorvastatin before the procedure,
- •*patients already receiving 80 mg atorvastatin, patients requiring dialysis and those with eGFR less than 15 ml/min/ 1.73 m2,
- •*patients who were exposed to a contrast medium within 7 days, patients with an allergy to contrast media,
- •*patients with cardiogenic shock or severe cardiac insufficiency (left ventricular ejection fraction LVEF <20%),
- •*patients with severe liver damage, malignant tumor, infectious disease, or fever,
- •*and those who refused to consent.
- •* patients who didn't return to get control laboratory tests
研究者
相似试验
已完成
不适用
Effect of Atorvastatin and CoQ10 on strokeischemic stroke.Cerebral infarctionIRCT2017041731773N1Vice chancellor for research, Shahid Beheshti University of Medical Sciences60
进行中（未招募）
1 期
TRial of Atorvastatin for the primary prevention of Cardiovascular Events in Rheumatoid Arthritis - TRACE RARheumatoid arthritis is associated with increased mortality from cardiovascular disease (CVD). Statins have a proven effect in reducing CVD events in at-risk populations, mostly due to their cholesterol-lowering properties, but possibly through anti-inflammatory and immunomodulatory effects. This trial will assess the hypothesis that atorvastatin is more effective than placebo in the primary prevention of cardiovascular events in patients with RA.EUCTR2006-006032-22-GBniversity of Manchester5,350
已完成
3 期
Effect of Atorvastatin in Helicobacter pylori eradicatioHelicobacter pylori infection.IRCT20190823044589N1Oroumia University of Medical Sciences120
招募中
不适用
Evaluation of the effect of Atorvastatin in diabetic type 2 patients in the morning and eveningIRCT20211211053359N1Babol University of Medical Sciences76
招募中
3 期
The effect of atorvastatin administration on the outcome of patients with traumatic brain injuryIRCT20210113050023N1Ahvaz University of Medical Sciences60